PB Fintech rebounds 4% as regulatory risk takes centre stage

Limited rebounded 4% to ₹1,256 on September 25 after plunging 36% in the previous session. The sharp fall followed proposed IRDAI changes to insurance distribution commissions, while HSBC cut its target to ₹1,150 from ₹2,100 and reduced its FY28 EPS estimate by 56%. My view is that regulatory changes are now the key variable for Policybazaar’s earnings outlook. Motilal Oswal estimates the proposals could reduce PB Fintech’s FY28 core online insurance revenue by around 30%. Without cost or other revenue offsets, it sees a potential 46% cut to earnings estimates. The rebound does not remove the underlying uncertainty. HSBC has downgraded the stock to Hold, while Motilal Oswal has maintained a Neutral view, with both brokerages highlighting regulatory risks. Final regulations will determine the actual impact on commission income and profitability. The key triggers to watch are the final IRDAI framework, impact on insurance commissions, Policybazaar’s revenue growth and its ability to offset any pressure through higher volumes or other income streams. My stance: The 36% correction has reset expectations, but regulatory clarity remains the key near-term trigger for PB Fintech. Disclosure: I do not hold any position in PB Fintech Limited (POLICYBZR). This post is for informational purposes only and is not investment advice.